COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
News
Plant Virus Plus Immune Cell-Activating Antibody Clear Colon Cancer in Mice, Prevent Recurrence
A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system’s “natural killer” cells, shows a study by UC San Diego researchers. In mouse mo… […]
News
UC San Diego Health Recognized by Vizient in 2021 Birnbaum Quality Leadership Performance Ranking
UC San Diego Health announces it has been recognized as a top performer in the 2021 Bernard A. Birnbaum, MD, Quality Leadership Annual Ranking by Vizient Inc. Click here to view original post… […]
News
UC San Diego Forging a Sustainable Future with Renewable Products
Although they were introduced back in the 1950s, the true dawn of plastics is rooted in the 1970s. The ’70s ushered in a meteoric rise in everyday consumer plastics. Single-use straws, product packaging, omnipre… […]
